Marty Marchak was diagnosed with stage I non-Hodgkin skin lymphoma, which then began his chemotherapy and radiation journey at the U-M Rogel Cancer Center. Fortunately, after his second chemotherapy session in early December 2018, doctors informed Marchak that the treatments worked and that the remaining chemotherapy and radiation could be discontinued. At first, Marchak had no pain or side effects from his treatment except for being more tired than usual. But then, suddenly, unusual symptoms started to appear.